Literature DB >> 32417712

IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.

Yangsean Choi1, Yoonho Nam2, Youn Soo Lee3, Jiwoong Kim1, Kook-Jin Ahn4, Jinhee Jang1, Na-Young Shin1, Bum-Soo Kim1, Sin-Soo Jeon5.   

Abstract

PURPOSE: This study aimed to determine whether MR-based radiomics of glioblastoma can predict the isocitrate dehydrogenase-1 (IDH1) mutation status and compare predictive performances between manual and fully automatic deep-learning segmentations.
METHOD: Forty-five glioblastoma patients with pretreatment T2-weighted MRIs were retrospectively evaluated. Manual segmentations of glioblastoma and peri-tumoral edema were trained via a deep neural network (V-Net). An independent external cohort of 137 glioblastoma patients from the Cancer Imaging Archive was also included (test set 1, n = 46; test set 2, n = 91). Test set 1-without known IDH1 status-was used to calculate dice similarity coefficients (DSC) between the two segmentation methods (manual & V-Net). From test set 2, all-relevant radiomic features were selected via a random forest-based wrapper algorithm for IDH1 prediction. Receiver operating characteristics (ROC) curves with areas under the curve (AUC) were plotted as performance metrics for both methods.
RESULTS: Among 136 patients (45 and 91 patients from our institution and test set 2, respectively), 17 patients (11.2 %) had IDH1 mutations. The mean DSC of test set 1 was 0.78 ± 0.14 (range, 0.34-0.94). A subset of 9 all-relevant features (8.4 %, 9/107) was selected. V-Net segmentation of the test set 2 yielded similar performance in predicting IDH1 mutation as compared to manual segmentation (V-Net AUC = 0.86 vs. manual AUC = 0.90). The optimal cut-point threshold of AUC yielded 86.8 % accuracy for manual segmentation and 75.8 % for V-Net segmentation.
CONCLUSIONS: V-Net showed robust segmentation capability of glioblastoma on T2-weighted MRI. All-relevant radiomics features from both segmentation methods yielded a similar performance in IDH1 prediction.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  glioblastoma; isocitrate dehydrogenase; machine learning; magnetic resonance imaging; sensitivity and specificity

Mesh:

Substances:

Year:  2020        PMID: 32417712     DOI: 10.1016/j.ejrad.2020.109031

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant.

Authors:  Beomseok Sohn; Chansik An; Dain Kim; Sung Soo Ahn; Kyunghwa Han; Se Hoon Kim; Seok-Gu Kang; Jong Hee Chang; Seung-Koo Lee
Journal:  J Neurooncol       Date:  2021-10-14       Impact factor: 4.130

Review 2.  Radiomics and radiogenomics in ovarian cancer: a literature review.

Authors:  S Nougaret; Cathal McCague; Hichem Tibermacine; Hebert Alberto Vargas; Stefania Rizzo; E Sala
Journal:  Abdom Radiol (NY)       Date:  2020-11-11

3.  Deep learning identified glioblastoma subtypes based on internal genomic expression ranks.

Authors:  Xing-Gang Mao; Xiao-Yan Xue; Ling Wang; Wei Lin; Xiang Zhang
Journal:  BMC Cancer       Date:  2022-01-20       Impact factor: 4.430

Review 4.  Performance of machine learning algorithms for glioma segmentation of brain MRI: a systematic literature review and meta-analysis.

Authors:  Evi J van Kempen; Max Post; Manoj Mannil; Richard L Witkam; Mark Ter Laan; Ajay Patel; Frederick J A Meijer; Dylan Henssen
Journal:  Eur Radiol       Date:  2021-05-21       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.